Jazz Pharmaceuticals is reaching into its wallet once again, this time buying Actio Biosciences and an experimental therapy for KCNT1+ epilepsy, a form of the disease with no FDA-approved treatments.
How many musical masterpieces have been censured by the United Nations? When Paul Simon’s Graceland was released in August ...
Joe Schatz is the deputy editor-in-chief of POLITICO. DEVENS, Massachusetts — On a rainy July day at Commonwealth Fusion Systems, a former U.S. Army base-turned-research park forty miles northwest of ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The writer is director of the Columbia Fusion Research Center and associate professor of applied physics at ...
Standouts from the local Texas Fusion Elite youth track and field program will look to represent Galveston County on a major stage when they compete at the upcoming AAU Junior Olympics. In all, nine ...